133 related articles for article (PubMed ID: 26181364)
1. Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6.
Volz Y; Koschut D; Matzke-Ogi A; Dietz MS; Karathanasis C; Richert L; Wagner MG; Mély Y; Heilemann M; Niemann HH; Orian-Rousseau V
Biosci Rep; 2015 Jun; 35(4):. PubMed ID: 26181364
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells.
Sulpice E; Ding S; Muscatelli-Groux B; Bergé M; Han ZC; Plouet J; Tobelem G; Merkulova-Rainon T
Biol Cell; 2009 Sep; 101(9):525-39. PubMed ID: 19281453
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
4. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis.
Tremmel M; Matzke A; Albrecht I; Laib AM; Olaku V; Ballmer-Hofer K; Christofori G; Héroult M; Augustin HG; Ponta H; Orian-Rousseau V
Blood; 2009 Dec; 114(25):5236-44. PubMed ID: 19773544
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
[TBL] [Abstract][Full Text] [Related]
6. Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B.
Tannoo RM; Richert L; Koschut D; Tomishige N; Treffert SM; Kobayashi T; Mély Y; Orian-Rousseau V
Biochim Biophys Acta Biomembr; 2024 Jan; 1866(1):184236. PubMed ID: 37793560
[TBL] [Abstract][Full Text] [Related]
7. Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity.
Kaya M; Çokakli M; Berk AT; Yaman A; Yesilirmak D; Kumral A; Atabey N
Curr Eye Res; 2013 Jan; 38(1):137-42. PubMed ID: 23094709
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.
Lashkari K; Hirose T; Yazdany J; McMeel JW; Kazlauskas A; Rahimi N
Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359
[TBL] [Abstract][Full Text] [Related]
9. MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.
Chen TT; Filvaroff E; Peng J; Marsters S; Jubb A; Koeppen H; Merchant M; Ashkenazi A
EBioMedicine; 2015 May; 2(5):406-20. PubMed ID: 26137585
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
[TBL] [Abstract][Full Text] [Related]
12. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death.
Osada S; Imai H; Tomita H; Tokuyma Y; Okumura N; Sakashita F; Nonoka K; Sugiyama Y
J Gastroenterol Hepatol; 2006 Jun; 21(6):988-93. PubMed ID: 16724983
[TBL] [Abstract][Full Text] [Related]
15. CD44-independent activation of the Met signaling pathway by HGF and InlB.
Dortet L; Veiga E; Bonazzi M; Cossart P
Microbes Infect; 2010 Nov; 12(12-13):919-27. PubMed ID: 20670691
[TBL] [Abstract][Full Text] [Related]
16. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice.
Khan F; Gurung S; Gunassekaran GR; Vadevoo SMP; Chi L; Permpoon U; Haque ME; Lee YK; Lee SW; Kim S; Lee B
Theranostics; 2021; 11(3):1326-1344. PubMed ID: 33391537
[TBL] [Abstract][Full Text] [Related]
18. Live cell imaging shows hepatocyte growth factor-induced Met dimerization.
Koschut D; Richert L; Pace G; Niemann HH; Mély Y; Orian-Rousseau V
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1552-8. PubMed ID: 27094128
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CD44v6 in InlB-dependent Listeria invasion.
Jung C; Matzke A; Niemann HH; Schwerk C; Tenenbaum T; Orian-Rousseau V
Mol Microbiol; 2009 Jun; 72(5):1196-207. PubMed ID: 19432801
[TBL] [Abstract][Full Text] [Related]
20. Cerebral hemorrhage therapy by targeting VEGF and HGF in a preclinical trial in rats.
Li X; Cao R; Lu H; Tian W; Yu N; Zhang P; Dong Z
Mol Med Rep; 2017 May; 15(5):3093-3098. PubMed ID: 28339025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
